BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35507154)

  • 1. Distinguishing Between Endodermal and Pluripotent Stem Cell Lines During Somatic Cell Reprogramming.
    Moauro A; Ralston A
    Methods Mol Biol; 2022; 2429():41-55. PubMed ID: 35507154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
    Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
    Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent Reporters Distinguish Stem Cell Colony Subtypes During Somatic Cell Reprogramming.
    Moauro A; Kruger RE; O'Hagan D; Ralston A
    Cell Reprogram; 2022 Dec; 24(6):353-362. PubMed ID: 36342671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb.
    Feng B; Jiang J; Kraus P; Ng JH; Heng JC; Chan YS; Yaw LP; Zhang W; Loh YH; Han J; Vega VB; Cacheux-Rataboul V; Lim B; Lufkin T; Ng HH
    Nat Cell Biol; 2009 Feb; 11(2):197-203. PubMed ID: 19136965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile and efficient reprogramming of ciliary body epithelial cells into induced pluripotent stem cells.
    Ni A; Wu MJ; Nakanishi Y; Chavala SH
    Stem Cells Dev; 2013 Sep; 22(18):2543-50. PubMed ID: 23635313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
    Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
    Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction.
    Liu X; Chen J; Firas J; Paynter JM; Nefzger CM; Polo JM
    Methods Mol Biol; 2019; 1940():63-76. PubMed ID: 30788818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological importance of OCT transcription factors in reprogramming and development.
    Kim KP; Han DW; Kim J; Schöler HR
    Exp Mol Med; 2021 Jun; 53(6):1018-1028. PubMed ID: 34117345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
    Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
    Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
    Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
    Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
    Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
    Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.
    Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T
    Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT4 is expressed in extraembryonic endoderm stem (XEN) cell progenitors during somatic cell reprogramming.
    Moauro A; Hickey SL; Halbisen MA; Parenti A; Ralston A
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
    Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
    Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.